Effects of Remifemin Treatment on Bone Integrity and Remodeling in Rats with Ovariectomy-Induced Osteoporosis
Open Access
- 9 December 2013
- journal article
- research article
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 8 (12) , e82815
Abstract
This study aims to evaluate the effects of Remifemin (isopropanolic extract of Cimicifuga Racemosa) on postmenopausal osteoporosis. 120 female Sprague-Dawley rats were randomly assigned to four groups: sham surgery with vehicle, ovariectomy with vehicle, ovariectomy with estradiol valerate, or ovariectomy with Remifemin. Daily oral administrations of the vehicle, estradiol valerate, or Remifemin began 2 weeks after surgery and lasted to 4, 8, or 12 weeks. Ten rats in each group were sacrificed at each timestep with assessment of bone mineral density, trabecular bone structure, and biomechanical parameters of the femur and lumbar vertebra. Bone turnover markers were evaluated 12 weeks after surgery. Both drugs prevented bone density loss in the distal end of the femur and preserved the trabecular bone structure in both the lumbar vertebra and distal end of the femur following ovariectomy. Both drugs protected bone stiffness at the tested regions and reduced bone reabsorption in ovariectomized rats. The preventive effects of Remifemin against bone-loss can rival those of estradiol valerate if treatment duration is adequately extended. In conclusion, Remifemin may demonstrate equivalent effects to estradiol valerate in terms of preventing postmenopausal osteoporosis.Keywords
This publication has 47 references indexed in Scilit:
- Strontium fructose 1,6-diphosphate prevents bone loss in a rat model of postmenopausal osteoporosis via the OPG/RANKL/RANK pathwayActa Pharmacologica Sinica, 2012
- Clinical utility of clodronate in the prevention and management of osteoporosis in patients intolerant of oral bisphosphonatesDrug Design, Development and Therapy, 2011
- Suspected black cohosh hepatotoxicityMenopause, 2011
- Black Cohosh Hepatic Safety: Follow-Up of 107 Patients Consuming a SpecialCimicifuga racemosa rhizomeHerbal Extract and Review of LiteratureEvidence-Based Complementary and Alternative Medicine, 2011
- Osteonecrosis of jaws related to intravenous bisphosphonates: the experience of a Jordanian teaching hospitalThe Annals of The Royal College of Surgeons of England, 2010
- Osthole stimulates osteoblast differentiation and bone formation by activation of β-catenin–BMP signalingJournal of Bone and Mineral Research, 2010
- Serum Biomarker Profile Associated With High Bone Turnover and BMD in Postmenopausal WomenJournal of Bone and Mineral Research, 2008
- Serum TRACP 5b Is a Useful Marker for Monitoring Alendronate Treatment: Comparison With Other Markers of Bone TurnoverJournal of Bone and Mineral Research, 2005
- Osteoclast differentiation and activationNature, 2003
- Hip fractures in the elderly: A world-wide projectionOsteoporosis International, 1992